Canada· CA-DIN-02442175
MOVANTIK
A naloxegol product containing naloxegol (naloxegol oxalate), registered in Canada by KNIGHT THERAPEUTICS INC.. The same ATC class is registered in 15 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Naloxegol is registered in 15 of 19 countries.
Countries holding a registration under ATC A06AH03 (naloxegol), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 10 of them publish a price we can compare per daily dose
Naloxegol · ATC A06AH03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of naloxegol costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $3.62 in Italy to $5.84 in Spain — a ×1.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Naloxegol · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- ES Spain$5.84
- CH Switzerland$5.75
- FR France$3.80
- IT Italy$3.62
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- NALOXEGOL (NALOXEGOL OXALATE)
- Manufacturer
- KNIGHT THERAPEUTICS INC.
- Country
- Canada (CA)
- ATC code
- A06AH03
- ATC class
- Naloxegol
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
204 interactions on record for naloxegol.
Graded by severity as the source publishes them — 66 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naloxegol · interactions on record
204 records
- 66 severe
- 57 moderate
- 81 minor
Most severe, free to view
- AprepitantA04AD12severe
- DanazolG03XA01severe
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Naloxegol in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMoventig 25mg tabletsGrunenthal Ltd
- SwitzerlandMoventig 12.5 mg, FilmtablettenCederberg GmbH
- SpainMOVENTIG 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGrünenthal Gmbh
- FranceMOVENTIG 12,5 mg, comprimé pelliculéGRUNENTHAL
- IcelandMoventigGrünenthal GmbH*
- SwedenMoventig 12,5 mg Filmdragerad tablettGrünenthal GmbH
- NorwayMoventigGrünenthal GmbH
- PolandMoventigGruenenthal GmbH
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Moventig
- Iceland · Moventig
- Liechtenstein · Moventig
- Norway · Moventig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b91a2736-3edf-4c6d-92ad-cf0e82542c95 GET /v1/drugs/b91a2736-3edf-4c6d-92ad-cf0e82542c95?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02442175",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A06AH03",
"schedule": [
"Prescription"
],
"drug_code": "92653",
"strengths": [
"25 MG"
],
"ahfs_class": null,
"substances": [
"NALOXEGOL (NALOXEGOL OXALATE)"
],
"product_categorization": null
}See everything about naloxegol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.